{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "The Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel"
  ],
  "article_type": "New results",
  "arxiv": null,
  "author_total": 21,
  "authors": [
    {
      "name": "M. D. Shmueli"
    },
    {
      "name": "T. Yongfeng"
    },
    {
      "name": "E. Singh"
    },
    {
      "name": "M. P. Kramer"
    },
    {
      "name": "A. Abramov"
    },
    {
      "name": "T. Aizik"
    },
    {
      "name": "D. Sheban"
    },
    {
      "name": "A. Lobov"
    },
    {
      "name": "K. Goldberg"
    },
    {
      "name": "A. Ibraheem"
    },
    {
      "name": "R. Shteinvil"
    },
    {
      "name": "A. Javitt"
    },
    {
      "name": "Y. Levin"
    },
    {
      "name": "M. A. Schafroth"
    },
    {
      "name": "D. Ogasawara"
    },
    {
      "name": "J. Gross"
    },
    {
      "name": "F. Adolf"
    },
    {
      "name": "B. Melillo"
    },
    {
      "name": "B. A. Schulman"
    },
    {
      "name": "B. F. Cravatt"
    },
    {
      "affs": [
        0
      ],
      "name": "Y. Merbl"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/1t6a2ac18pq8q.bib",
  "cited_by": 0,
  "doi": "10.64898/2026.10.15.759172",
  "fulltext_url": "https://www.biorxiv.org/content/10.64898/2026.10.15.759172v1.full",
  "id": "1t6a2ac18pq8q",
  "issns": [],
  "landing_url": "https://www.biorxiv.org/content/10.64898/2026.10.15.759172v1",
  "language": null,
  "licence": "LicenseRef-all-rights-reserved",
  "licence_label": "All rights reserved",
  "licence_source": "article",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "biorxiv",
      "cancer biology"
    ],
    [
      "openalex",
      "1312|Ubiquitin and proteasome pathways"
    ]
  ],
  "openalex": "W7222743855",
  "pdf_url": "https://www.biorxiv.org/content/10.64898/2026.10.15.759172v1.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-15",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/1t6a2ac18pq8q.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:28:06Z",
      "native_id": "10.64898/2026.10.15.759172",
      "source": "biorxiv",
      "url": "https://www.biorxiv.org/content/10.64898/2026.10.15.759172v1"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "biorxiv:cancer biology",
      "subfield": "oncology"
    }
  ],
  "title": "Targeting proteasome composition reprograms tumor-intrinsic inflammation through selective degradation of STAT1",
  "title_text": "Targeting proteasome composition reprograms tumor-intrinsic inflammation through selective degradation of STAT1",
  "type": "preprint",
  "updated_at": "2026-10-30T12:28:06Z",
  "url": "https://research.draconitic.com/paper/1t6a2ac18pq8q",
  "venue": "bioRxiv",
  "versions": []
}